Abstract
Conformationally constrained bithiazoles were previously found to have improved efficacy over nonconstrained bithiazoles for correction of defective cellular processing of the ΔF508 mutant cystic fibrosis transmembrane conductance regulator (CFTR) protein. In this study, two sets of constrained bithiazoles were designed, synthesized, and tested in vitro using ΔF508-CFTR expressing epithelial cells. The SAR data demonstrated that modulating the constraining ring size between 7- versus 8-membered in these constrained bithiazole correctors did not significantly enhance their potency (IC50), but strongly affected maximum efficacy (Vmax), with constrained bithiazoles 9e and 10c increasing Vmax by 1.5-fold compared to benchmark bithiazole corr4a. The data suggest that the 7- and 8-membered constrained ring bithiazoles are similar in their ability to accommodate the requisite geometric constraints during protein binding.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Animals
-
Cells, Cultured
-
Cycloheptanes / chemical synthesis
-
Cycloheptanes / chemistry*
-
Cycloheptanes / pharmacology
-
Cyclooctanes / chemical synthesis
-
Cyclooctanes / chemistry*
-
Cyclooctanes / pharmacology
-
Cystic Fibrosis Transmembrane Conductance Regulator / genetics
-
Cystic Fibrosis Transmembrane Conductance Regulator / metabolism*
-
Epithelial Cells / drug effects
-
Epithelial Cells / metabolism
-
Humans
-
Mutation
-
Protein Transport
-
Rats
-
Structure-Activity Relationship
-
Thiazoles / chemical synthesis
-
Thiazoles / chemistry*
-
Thiazoles / pharmacology
-
Thyroid Gland / cytology
Substances
-
Cycloheptanes
-
Cyclooctanes
-
N-(9-((5-chloro-2-methoxyphenyl)amino)-4,5,6,7-tetrahydrocycloocta(1,2-d-3,4-d')bis(thiazole)-2-yl)isobutyramide
-
Thiazoles
-
methyl 4-((8-((5-chloro-2-methoxyphenyl)amino)-5,6-dihydro-4H-cyclohepta(1,2-d-3,4-d')bis(thiazole)-2-yl)amino)-4-oxobutanoate
-
Cystic Fibrosis Transmembrane Conductance Regulator